News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Theratechnologies Inc. (TH.TO) Closes The Sale Of Its Investment In Celmed BioSciences


10/19/2005 5:09:19 PM

MONTREAL, June 20 /CNW Telbec/ - Theratechnologies (TSX : TH) today announced the sale of its 37% investment in Celmed BioSciences (Celmed) for total proceeds of up to $ 8.4 million. The acquirer is a group of minority shareholders of Celmed.

Read at Canada NewsWire


comments powered by Disqus
   
HIV/AIDS

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES